[The role of LH-RH analogues in the treatment of prostate cancer. Report of a conference organized by ICI-Pharma laboratories (part 2)].
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D004359:Drug Therapy, Combination; D005485:Flutamide / Q000008:administration & dosage / Q000627:therapeutic use*; D017273:Goserelin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009919:Orchiectomy / Q000523:psychology; D017060:Patient Satisfaction; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D015996:Survival Rate
D017273:Goserelin; D005485:Flutamide
La place des analogues de la LH-RH dans le traitement du cancer de la prostate. Compte rendu de la conférence organisée par les laboratoires ICI-pharma. (2ème partie).